
March 20, 2024
Gold Mountain Limited (ASX: GMN) (“Gold Mountain” or “the Company” or “GMN”) is pleased to announce it has visually identified numerous occurrences of both leucogranites and of charnockite in five of its tenements and silicified and sheared rocks that are often associated with good REE values.
Highlights
- Charnockite and leucogranites identified as well as sheared and silicified rocks
- Stream sediment sampling and mapping progressing well
- Favourable weathering profiles present
- Satellite imagery interpretation is in progress at present
GMN is delighted to announce that it has identified widespread charnockite and leucogranites in the five tenements in which stream sediment sampling is progressing. Charnockite is widespread and leocogranites have been identified at three locations in three separate tenements.
Sheared and silicified rocks have also been identified. The sheared rock found is a type that is often associated with high REE values according to one of our personnel with over 4 years experience working on REE in the region. Channel sampling of those exposures has been undertaken and samples are being prepared for dispatch.


The silicified rocks will also be sampled as they are also can be associated with high grade REE values.

Sampling commenced in tenements that are within 1.4 km of high-grade mineralisation drilled and reported by Brazilian Rare Earths in their Prospectus (lodged ASX 13 November 2023). There is no guarantee that GMN will have similar levels of results to results achieved by BRE, however they do assist in forming a basis for planned and targeted exploration.
Click here for the full ASX Release
This article includes content from Gold Mountain, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
The Conversation (0)
02 June
Ronald-Peter Stoeferle: Gold Price Hasn't Topped, on Track for US$8,900
Ronald-Peter Stoeferle of Incrementum shares takeaways from the latest "In Gold We Trust" report, emphasizing that gold is currently in a bull market consolidation phase.Overall he believes the yellow metal is in the midst of a "golden decade" that will ultimately take it to his price target of... Keep Reading...
02 June
Chinese Regulator Delays Zijin Gold’s US$4 Billion Allied Gold Takeover
Beijing’s National Development and Reform Commission (NDRC) has delayed regulatory approval for Zijin Gold International's (HKEX:2259,OTCPL:ZJNGF) US$4 billion acquisition of Allied Gold (TSX:AAUC,NYSE:AAUC), questioning the transaction premium and the political risks of the target's mining... Keep Reading...
29 May
Editor's Picks: Gold, Silver Face Bumpy Week as Prices Drop, Then Rebound
It was a bumpy week for the gold price, which dropped to the US$4,370 per ounce level midway through the period before rebounding back above US$4,500.Silver put on a similar performance, bottoming out at US$72 per ounce.Both precious metals were reacting to a complex array of dynamics, including... Keep Reading...
28 May
Precious Metals News: Gold, Silver and PGM Price Floors Hold Up Against Headwinds
The precious metals complex is proving resilient in the face of intensifying macroeconomic headwinds and ongoing uncertainty over the direction of the conflict in the Middle East. Prices for gold, silver, platinum and palladium fell below key psychological levels this week on the back of hawkish... Keep Reading...
27 May
Stephen Leeb: Gold Price to US$18,000? Here's How it Can Happen
Dr. Stephen Leeb of Leeb Capital Management shares his outlook for gold, explaining how the yellow metal could get to US$18,000 per ounce. "Gold's high point might not ever really be defined, because I think at the end of this period that we're in, you're going to find gold at the center of the... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00





